Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

A Study to Evaluate the Safety of Empliciti® (Elotuzumab) When Treating Patients With Multiple Myeloma in Taiwan

NCT06163040

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Chang Gung Memorial Hospital- Chiayi Chiayi City, Chiayi, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • National Taiwan University Hospital Taipei, Taiwan
  • China Medical University Hospital Taoyuan City, Taiwan
View Trial Details
Completed

A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma

NCT03548207

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic Cancer Center-Scottsdale Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Francisco San Francisco, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 21 locations
View Trial Details
Completed

Role of Monocytes Sub-populations in Thrombosis Associated With Myeloproliferative Neoplasms (MonSThr)

NCT05419648

Conditions
Bone Marrow Diseases, Cardiovascular Diseases, Embolism and Thrombosis, +6 more
Locations
  • CHU de Bordeaux, Hématologie clinique et thérapie cellulaire Bordeaux, France
  • CHU de Bordeaux, Laboratoire Hématologie Bordeaux, France
  • CHU de Bordeaux, Médecine interne et immunologie clinique Bordeaux, France
  • CHU de Bordeaux, Médecine Interne et maladies infectieuses Bordeaux, France
View Trial Details
Completed

Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation

NCT04621851

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • McGill University - Jewish General Hospital Division of Hematology and Department of Oncology Montreal, Quebec, Canada
  • Charité University of Berlin - Clinic of Medicine - Hematology and Oncology Berlin, Germany
  • University of Mannheim, Mannheim, Germania Mannheim, Germany
  • ASST-Monza Monza, Italy/MB, Italy
View all 26 locations
View Trial Details
Completed

Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children

NCT03939637

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Children's of Alabama Birmingham, Alabama, United States
  • Phoenix CHildren's Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Children's Hospital of Orange County Orange, California, United States
View all 27 locations
View Trial Details

Related conditions